Philips AI-powered interventional and diagnostic smart systems enhances diagnostic confidence, drive greater efficiency, and improve patient outcomes
The cash consideration for the above acquisition will be Euro 26 million.
Phase 2 Study of MK-2060 Currently Ongoing in People with End-Stage Renal Disease Receiving Hemodialysis
The funding round also saw participation from some of India's top angel investors and leading industry giants
The citizens of Oman will soon have a coordination center that will provide end to end services for healthcare facilities of Jaslok.
The summit to demonstrate revolutionary techniques and advanced medical procedures for treating CTO
~96% decline reported in Malaria cases in Madhya Pradesh, due to public-private-people partnership
GlobalData’s ‘Pharmaceutical Intelligence Center’ observes that India is still in the nascent stage of developing these potential therapies as currently only four cell/gene therapy molecules are being developed in the country.
First PARP inhibitor to demonstrate clinical benefit in radiographic progression-free survival in combination with a new hormonal agent with or without homologous recombination repair gene mutations
Meclizine Hydrochloride Tablets had estimated annual sales of USD 29 million in the U.S.
Subscribe To Our Newsletter & Stay Updated
